Product name | Recombinant MERS-CoV Spike S1 Protein |
---|---|
Catalog No. | RP01303 |
Description | Recombinant MERS-CoV Spike S1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Tyr18-Glu725) of mers-cov Spike S1 (Accession #YP_009047204.1) fused with a mFc tag at the C-terminus. |
Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Human CD26 (Catalog: RP01300LQ) at 2μg/mL (100μL/well) can bind MERS-CoV Spike S1 with a linear range of 0.5-420.21ng/mL. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
Species | MERS-CoV |
Calculated MW | 104.08 kDa |
Synonym | MERS-CoV Spike RBD |
---|---|
Expression Host | HEK293 cells |
Tag | C-mFc |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01303? Please let us know so that we can cite the reference in this datasheet.